Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ–STAT3 Signaling in Type 1-Like Diabetic Rats
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1364
Publisher
MDPI AG
Online
2017-06-27
DOI
10.3390/ijms18071364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding STAT3 signaling in cardiac ischemia
- (2016) K. E. O’Sullivan et al. BASIC RESEARCH IN CARDIOLOGY
- Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
- (2016) Wei-Ting Chang et al. Cardiovascular Diabetology
- Cardiac Fibrosis
- (2016) Joshua G. Travers et al. CIRCULATION RESEARCH
- Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat
- (2016) Hana Cernecka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lung damage induced by hyperglycemia in diabetic rats: The role of signal transducer and activator of transcription 3 (STAT3)
- (2016) Ching-Min Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Different effects of the nonsteroidal anti-inflammatory drugs meclofenamate sodium and naproxen sodium on proteasome activity in cardiac cells
- (2016) Rajeshwary Ghosh et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Finding and Producing Probiotic Glycosylases for the Biocatalysis of Ginsenosides: A Mini Review
- (2016) Seockmo Ku MOLECULES
- Plant Natural Product Formononetin Protects Rat Cardiomyocyte H9c2 Cells against Oxygen Glucose Deprivation and Reoxygenation via Inhibiting ROS Formation and Promoting GSK-3βPhosphorylation
- (2016) Yuanyuan Cheng et al. Oxidative Medicine and Cellular Longevity
- Roles and mechanisms of ginsenoside in cardiovascular diseases: progress and perspectives
- (2016) Yingying Sun et al. Science China-Life Sciences
- STAT3, a key regulator of cell-to-cell communication in the heart
- (2014) Arash Haghikia et al. CARDIOVASCULAR RESEARCH
- The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-β1 in the myocardium of rats with diabetes
- (2014) Lingling Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4
- (2014) Yunzi Ma et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Signals for increase of μ-opioid receptor expression in muscle by hyperglycemia
- (2014) Meng Ching Yeh et al. NEUROSCIENCE LETTERS
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
- (2014) Chang Ho Lee et al. Journal of Ginseng Research
- Merit of Ginseng in the Treatment of Heart Failure in Type 1-Like Diabetic Rats
- (2014) Cheng-Chia Tsai et al. Biomed Research International
- Naringin Inhibits ROS-activated MAPK Pathway in High Glucose-induced Injuries in H9c2 Cardiac Cells
- (2013) Jingfu Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
- (2013) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate
- (2013) Zhih-Cherng Chen et al. PLoS One
- Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
- (2012) Chun-jun Li et al. Cardiovascular Diabetology
- Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced CardiotoxicityIn VitroandIn Vivo
- (2012) Hongbo Wang et al. Evidence-based Complementary and Alternative Medicine
- Diabetic cardiomyopathy
- (2012) BR Goyal et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice
- (2012) Hui-Ting Wang et al. Journal of Translational Medicine
- Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats
- (2012) Yang Liu et al. PHYTOMEDICINE
- Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARδ) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity
- (2012) Heidi E. Kocalis et al. PLoS One
- Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line
- (2011) Zhih-Cherng Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- JAK-STAT signaling in hepatic fibrosis
- (2011) Markus Mair Frontiers in Bioscience-Landmark
- Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
- (2011) Inês Falcão-Pires et al. HEART FAILURE REVIEWS
- Janus Kinase 2/Signal Transducers and Activators of Transcription Signal Inhibition Regulates Protective Effects of Probucol on Mesangial Cells Treated with High Glucose
- (2010) Juan Du et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53
- (2010) Binghui Li et al. CANCER LETTERS
- Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
- (2010) K. Huynh et al. DIABETES
- Oxidative stress and inflammation modulate peroxisome proliferator-activated receptors with regional discrepancy in diabetic heart
- (2010) Ting-I. Lee et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-β/δ ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN THE RAT
- (2010) Amar Kapoor et al. SHOCK
- Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases
- (2009) Claudio Napoli et al. ARCHIVES OF PHARMACAL RESEARCH
- Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy
- (2009) Alain G. Musende et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiac Fibroblast
- (2009) Colby A. Souders et al. CIRCULATION RESEARCH
- Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs
- (2009) Yi Gu et al. FOOD AND CHEMICAL TOXICOLOGY
- Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
- (2009) Kay-Dietrich Wagner et al. PHARMACOLOGY & THERAPEUTICS
- Catheter replacement of the needle in percutaneous arteriography
- (2008) Sven Ivar Seldinger ACTA RADIOLOGICA
- New insights into form and function of fibronectin splice variants
- (2008) ES White et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now